ANI Pharmaceuticals to Discuss Second Quarter 2025 Financial Results on August 8, 2025, at 8:30 a.m. ET

Group 1 - ANI Pharmaceuticals, Inc. will release its second quarter 2025 financial results on August 8, 2025, prior to market open [1] - A conference call will be hosted by key executives to discuss the financial results on August 8, 2025, at 8:30 a.m. ET [2] - The company is focused on sustainable growth through its Rare Disease business, Generics business, and Brands business [3] Group 2 - The Rare Disease business markets novel products in ophthalmology, rheumatology, nephrology, neurology, and pulmonology [3] - ANI Pharmaceuticals is committed to developing, manufacturing, and commercializing innovative and high-quality therapeutics [3] - The company emphasizes its mission of "Serving Patients, Improving Lives" [3]